If you are having problems viewing this page, load here

GXPNews.com - FDA News and Announcements - September 22, 2008 - September 26, 2008
The once a week newsletter reporting on what's new within the Food and Drug Administration (FDA)
Conference Center  |  Discussion Board  |  Handbooks - EU / US GMP  -  US GMP - GLP - GCP - QSR more... | Fax Form | On-Demand Printing

GMP Publications new 2008 CFR Handbook LineupGMP Publications Medical Device Quality Systems Manual

GXP Academy
Conferences
Discussions
Handbooks
EU/US GMPs
GMP Training
Save 10% on your next order of Mini-Regulation Handbooks from GMP Publications, Inc.  

Distributed by the leader in Federal Regulations, GMP Publications, GXPNews & FDA.COM - RA/QA Editor

What's New - Medical Device Quality Manuals EU / US Compliance Handbooks  - GMP Training Courses

Stay up to date with the Code of Federal Regulations changes - Enter Email:     Archive

Center for Drug Evaluation &
Research (CDER) News
Center for Biologics Evaluation &
Research (CBER)
Center for Device &
Radiological Health (CDRH)

Federal Register - Meetings, Notices, &  Rule Changes

September 26, 2008

September 25, 2008

  • FDA orders companies to stop marketing unapproved drug products that contain papain in a topical dosage form. Questions and Answers (updated)
  • Guidance for Industry: End-of-Phase 2A Meetings [PDF] or [HTML]
  • International Conference on Harmonization (ICH) Public Meeting, October 21, 2008, Rockville, Maryland: Meeting information and registration - (updated)
  • New and Generic Drug Approvals
    • Amlodipine Besylate Tablets, Torrent Pharmaceuticals, Ltd., Approval
    • Carboplatin I.V. Injection, Sun Pharmaceutical Industries, Ltd., Approval
    • Nasacort AQ (triamcinolone acetonide) Nasal Spray, Sanofi-Aventis US, LLC, Patient Population Altered
    • RETROVIR (zidovudine) Capsules, GlaxoSmithKline, New Dosage Regimen
    • RETROVIR (zidovudine) Syrup, GlaxoSmithKline, New Dosage Regimen
    • RETROVIR (zidovudine) Tablets, GlaxoSmithKline, New Dosage Regimen
    • Tarceva (erlotinib hydrochloride) Tablets, OSI Pharmaceuticals, Inc., New Dosage Regimen
    • Technetium Tc 99m Sestamibi (technettium tc-99m sestamibi kit) Injection, Mallinckrodt Inc., Approval
    • Ventavis (iloprost) Inhalation Solution, Actelion, Ltd., Labeling Revision

September 24, 2008

September 23, 2008

September 22, 2008

  • FDA orders companies to stop marketing unapproved drug products that contain papain in a topical dosage form. Questions and Answers
  • FDA orders companies to stop marketing unapproved ophthalmic balanced salt solutions (BSS). Questions and Answers

CDER Drug Links


Hot Topics

CBER Links

 

September 26, 2008
* Federal Register: Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications TextPDF
* Summary Information for: NexGen LPS-Flex Mobile Bearing and LPS-Mobile Bearing Knees PDF
 
September 24, 2008
* Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; MedWatch: Food and Drug Administration Medical Products Reporting Program TextPDF
* FDA Public Health Notification: Radiofrequency Ablation of Lung Tumors - Clarification of Regulatory Status Text
 
September 22, 2008
* Guidance for Industry and FDA Review Staff - Intravascular Administration Sets Premarket Notification Submissions [510(k)] TextPDF
* PMA Final Decisions for August 2008 Text
 

News & Events

Falsely Elevated Blood Glucose Readings with a Point-of-Care Meter Due to a Maltose-Containing Intravenous Immune Globulin Product
Certification to Accompany Drug, Biological Product, and Device Applications or Submissions
Public Health Notifications:
Radiofrequency Ablation of Lung Tumors - Clarification of Regulatory Status
Possible Malfunction of Electronic Medical Devices Caused by Computed Tomography (CT) Scanning
Class I Medical Device Recalls -
Physio Control, Inc. LifePak CR Plus Automated External Defibrillators (AEDs)
Pacific Consolidated Industries LLC, Mobile Oxygen Storage Tank
Boston Scientific NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System
 

FDA Patient


Medical Device Links

This Week Rule Changes:

NONE

Friday, Sept. 26, 2008

NOTICES
Draft Guidance for Industry on End-of-Phase 2A Meetings; Availability,
55851–55852 [E8–22669]   [TEXT]  [PDF]

Medical Devices:
    
Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,
    
55852–55853 [E8–22668]   [TEXT]  [PDF]
 

Thursday, Sept. 25, 2008
NOTICES
Agency Information Collection Activities; Proposals, Submissions, and Approvals,
55516–55517 [E8–22636]   [TEXT]  [PDF]
 

Wed., Sept. 24, 2008

NOTICES
Agency Information Collection Activities; Proposals, Submissions, and Approvals,
55108–55111 [E8–22435]   [TEXT]  [PDF]
55111–55114 [E8–22440]   [TEXT]  [PDF]

Meetings:
    
Endocrinologic and Metabolic Drugs Advisory Committee,
    
55114–55115 [E8–22437]   [TEXT]  [PDF]
    
Product Tracing Systems for Fresh Produce,
    
55115–55122 [E8–22430]   [TEXT]  [PDF]
 

Tuesday, Sept. 23, 2008

NOTICES
Enforcement Action Dates:
    
Ophthalmic Balanced Salt Solutions for Ocular Surgical Procedures,
    
54829–54831 [E8–22305]   [TEXT]  [PDF]
    
Topical Drug Products Containing Papain,
    
54831–54834 [E8–22300]   [TEXT]  [PDF]
 

Monday, Sept. 22, 2008

NOTICES
Global Harmonization Task Force, Study Groups 1 and 5; Proposed and Final Documents; Availability; Correction,
54600 [E8–22094]   [TEXT]  [PDF]
 


Advertise

Sparta-Systems
PDA Training - New Brunswick
GXP and JVT
Bulk Copy Printing by GMP Publications

FDA Handbooks

EU - US - ICH GMP
Combination Product handbook
US GMP Training Booklet
Std. GMPs - Parts 11, 210, 211, 820 & ICH Q7
Med. Device - 11, 50, 54, 56, 807, 812, 814, 820, 510k/PMA
Clinical GCP - Parts 11, 50, 54, 56, 312, 314 & ICH E2A & E6
Multi-US GMPs 11, 58, 210/211, 600, 601, 610  & 820
Parts 210/211 - Drug GMPs
>210/211 with Part 11
>210/211 with Part 820
>210/211 with Parts 820 & 11
>210/211 w/ Keyword Index

Part 820 Quality Systems Regs

Part  58 - GLP Good Lab. Practice

Part 11 - Electronic Records w/ Scope and Applications

GLP 2 11 & 58 - Part 11 & 58

PDMA 11, 203 & 205 - Prescription Drug Marketing

11 & 210/211 w/ Keyword Index

11 & 820 Electronic Record and Quality Systems

Biological GMPs 600, 601, 610

more...

 

Job Board  Conference Center  Discussion Board  Handbooks - EU GMP US GMP - GLP - GCP - QSR more...

The e-Newsletter of
What's New with CDER, CDRH & CBER
Distributed by the worlds leader in Federal Regulations,
GMP Publications, Inc.  & FDA.COM
Tel: 866-GXPNews (or 856-810-7331)  Fax: 856-810-7339
http://www.gmppublications.com / http://www.fda.com    John Cuspilich, Sr. Editor, GXPNews

If you would like to advertise in this eNewsletter, call 856-810-1825